The use of recombinant human growth hormone in patients with Mucopolysaccharidoses and growth hormone deficiency: a case series

BACKGROUND: The treatment with recombinant human growth hormone in patients affected by Mucopolysaccharidoses (MPS) is considered whenever a concurrent diagnosis of growth hormone deficiency is demonstrated. The short- and long-term effects of recombinant human growth hormone in this selected cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Cattoni, A., Motta, S., Masera, N., Gasperini, S., Rovelli, A., Parini, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676577/
https://www.ncbi.nlm.nih.gov/pubmed/31370860
http://dx.doi.org/10.1186/s13052-019-0691-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676577/
https://www.ncbi.nlm.nih.gov/pubmed/31370860
http://dx.doi.org/10.1186/s13052-019-0691-1

Ejemplares similares